Authorized Generic Version of Apriso® Launched by Lupin Kumar Jeetendra | May 19, 2020 Pharma significant Lupin Limited (Lupin) declared the dispatch of approved nonexclusive adaptation of Bausch Health’s Apriso® (Mesalamine Extended-Release Capsules 0.375 g) in the U.S. Mesalamine Extended-Release Capsules 0.375 g (approved nonexclusive form) are shown for the support of abatement of ulcerative colitis in patients 18 years old and more seasoned. Mesalamine Extended-Release Capsules 0.375 g, …
Lincoln Pharmaceuticals Ltd receives European Union (EU) GMP approval Kumar Jeetendra | May 19, 2020 May 19, 2020: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has received the European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj in Gujarat. The certification will allow the company to market its products in all the 27 member countries of EU and also give access to …
Cipla files ANDA for generic version of GSK’s Advair Diskus® Kumar Jeetendra | May 18, 2020 Mumbai, India; May 18, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced its submission of an Abbreviated New Drug Application (ANDA) for Fluticasone propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (USFDA). The Company had …
Zydus Cadila gets provisional endorsement from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg Kumar Jeetendra | May 16, 2020 Zydus Cadila has gotten provisional endorsement from the USFDA to advertise Droxidopa Capsules, (US RLD: Northera®) in the qualities of 100 mg, 200 mg, and 300 mg. Droxidopa is utilized to treat indications of low pulse when standing, brought about by a specific ailment (neurogenic orthostatic hypotension-nOH). This drug can diminish indications of low circulatory …
FDA warns About Accuracy of Widely Used Abbott COVID-19 test Kumar Jeetendra | May 16, 2020 The Food and Drug Administration is forewarning people in general about the unwavering quality of a broadly utilized quick test for the coronavirus. The test, made by Abbott Laboratories, has been connected with mistaken outcomes that could dishonestly promise patients that they are not contaminated with the infection. The Trump organization has advanced the test …
Cipla announces its Q4 FY20 results demonstrating sustained growth momentum across core businesses and unlocking of respiratory pipeline Kumar Jeetendra | May 15, 2020 Mumbai, May 15, 2020: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its audited consolidated financial results for quarter ended March 31st, 2020. Key highlights of the quarter: India: The Rx business grew by 12% on a y-o-y basis recording a 3rd consecutive quarter of market beating growth. The trade Gx business revives strongly recording …
Sanofi says COVID-19 antibody will be accessible overall at the same time Kumar Jeetendra | May 15, 2020 Sanofi will guarantee that a potential antibody against COVID-19, whenever affirmed, arrives at all locales of the world simultaneously, the administrator of the French drugmaker said on Thursday. “There will be no specific development given to any nation,” Serge Weinberg disclosed to France 2 TV. “We are sorted out with a few assembling units. Some …
Unichem Laboratories gets EIR from USFDA for Roha API unit Kumar Jeetendra | May 15, 2020 Unichem Laboratories Limited has gotten the Establishment Inspection Report (EIR) from United Stated Food and Drug Administration (USFDA) on May 13, 2020 for our Active Pharmaceutical Ingredients (APIs) office at Roha. The United States Food and Drug Administration (USFDA) directed the assessment of our Roha office from seventeenth to 21st February 2020. Portions of UNICHEM …
NovaLead Pharma to conduct Phase 3 trial for its discovery for COVID-19 Kumar Jeetendra | May 14, 2020 NovaLead Pharma, the Pune based pioneer in the field of drug repurposing in India has announced that it has received ‘in principal’ clinical trial permission with DCG(I) for its Repurposed Drug discovery to treat moderate COVID-19. This approved drug codenamed NLP21 is in human use for several years for its original use without any side …
Specialists create Bluetooth-empowered thermometer with area sharing element Kumar Jeetendra | May 14, 2020 The coronavirus pandemic is giving route for a ton of new creations, including foot-worked handwash machines. On comparative lines, a group of scientists in Chennai’s National Hub for Healthcare Instrumentation Development (NHHID) have built up a Bluetooth-empowered thermometer. Notwithstanding following fever, the thermometer can likewise speak with a cell phone application and offer the area. …
Too right on time to discuss remdesivir pricing:Hetero Labs Kumar Jeetendra | May 14, 2020 It is too soon to discuss the estimating of remdesivir, as indicated by Vamsi Krishna Bandi, Managing Director of Hetero Labs. “In the following barely any weeks, we will get greater lucidity regarding gracefully chain and amounts. As of now, we are working with the legislature to comprehend what are the prerequisites. Cost will be …
Lupin’s Vizag unit gets examination conclusion report from USFDA Kumar Jeetendra | May 14, 2020 Pharma significant Lupin on Thursday said that its office in Vizag, Andhra Pradesh, has gotten the examination conclusion report from the US wellbeing controller. The review for the office was led by the United States Food and Drug Administration (USFDA) during January 13-17, the organization said. It educated stock trades regarding “the receipt of the …
